CLEAR CELL TUMOR OF THE LUNG - IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL EVIDENCE OF MELANOGENESIS

被引:132
作者
GAFFEY, MJ
MILLS, SE
ZARBO, RJ
WEISS, LM
GOWN, AM
机构
[1] HENRY FORD HOSP,DEPT PATHOL,DETROIT,MI 48202
[2] CITY HOPE NATL MED CTR,DUARTE,CA 91010
[3] UNIV WASHINGTON,SEATTLE,WA 98195
关键词
LUNG; SUGAR TUMOR; CLEAR CELL TUMOR; MELANOGENESIS; MELANOSOMES;
D O I
10.1097/00000478-199107000-00005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Clear cell tumors of the lung (CCTL) are rare neoplasms of uncertain differentiation. A previous study of eight CCTL demonstrated a lack of epithelial features, but their exact nature remained unknown. In the current study of nine CCTL, immunohistochemistry using preliminary enzymatic digestion showed strong reactivity with the antimelanocytic markers HMB-45 (seven cases) and HMB-50 (six cases) and focal positively for S-100 (nine cases), neuron-specific enolase (three cases), synaptophysin (one case), and Leu-7 (one case). Staining for cytokeratin, epithelial membrane antigen, chromogranin, and glial fibrillary acid protein was uniformly negative. Frozen-section immunoreactivity for vimentin and the antimelanocytic monoclonal preparation NKI/BETEB was noted in the one CCTL for which snap-frozen tissue was available. Ultrastructural examination of three glutaraldehyde-fixed CCTL showed rare neoplastic cells containing the full spectrum of melanosomes in two, one of which also contained neurosecretory-type granules. Aberrant melanosomal forms were identified in the third case. Melanosomes were not identified in the remaining five CCTL studied from formalin- or paraffin-retrieved material. The findings indicate that CCTL exhibits melanocytic differentiation. This feature may be of considerable value in distinguishing CCTL from other clear cell neoplasms.
引用
收藏
页码:644 / 653
页数:10
相关论文
共 54 条
[1]  
ANDRION A, 1985, CANCER, V56, P2657, DOI 10.1002/1097-0142(19851201)56:11<2657::AID-CNCR2820561121>3.0.CO
[2]  
2-U
[3]  
BECKER NH, 1971, CANCER, V527, P712
[4]   BREAST-CARCINOMA WITH POSITIVE RESULTS FOR MELANOMA MARKER (HMB-45) - HMB-45 IMMUNOREACTIVITY IN NORMAL AND NEOPLASTIC BREAST [J].
BONETTI, F ;
COLOMBARI, R ;
MANFRIN, E ;
ZAMBONI, G ;
MARTIGNONI, G ;
MOMBELLO, A ;
CHILOSI, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 92 (04) :491-495
[5]   FALSE-POSITIVE IMMUNOSTAINING OF NORMAL EPITHELIA AND CARCINOMAS WITH ASCITES-FLUID PREPARATIONS OF ANTIMELANOMA MONOCLONAL-ANTIBODY HMB45 [J].
BONETTI, F ;
PEA, M ;
MARTIGNONI, G ;
MOMBELLO, A ;
COLOMBARI, R ;
ZAMBONI, G ;
SCARPA, A ;
PIUBELLO, Q ;
BACCHI, CE ;
GOWN, AM .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (04) :454-459
[6]   MALIGNANT MELANOMAS CONTAIN ONLY THE VIMENTIN TYPE OF INTERMEDIATE FILAMENTS [J].
CASELITZ, J ;
JANNER, M ;
BREITBART, E ;
WEBER, K ;
OSBORN, M .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1983, 400 (01) :43-51
[7]  
CEBELIN MS, 1980, CANCER-AM CANCER SOC, V46, P1843, DOI 10.1002/1097-0142(19801015)46:8<1843::AID-CNCR2820460823>3.0.CO
[8]  
2-C
[9]  
CHAN R, 1986, CANCER RES, V46, P6353
[10]   MALIGNANT-MELANOMA OF SOFT PARTS - A REASSESSMENT OF CLEAR CELL-SARCOMA [J].
CHUNG, EB ;
ENZINGER, FM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1983, 7 (05) :405-413